EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Concomitant Psychotropic Medication Is Associated with Reduced Outcomes of Trauma-Focused Psychotherapy for Post-Traumatic Stress Disorder

Serge A Steenen, Roos van Westrhenen, Camilo C Steenen, L Thomas Klausch, Ad de Jongh

Psychotherapy and Psychosomatics · 2025

DOI: 10.1159/000549259 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Psychotherapy and Psychosomatics, 2025. Verfasst von Serge A Steenen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral Public Health, University of Amsterdam and VU University Amsterdam, Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Stress Disorders, Post-Traumatic, Psychotropic Drugs, Psychotherapy, Outcome Assessment, Health Care. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Psychotropic medications are frequently prescribed alongside trauma-focused psychotherapy for post-traumatic stress disorder (PTSD), yet their impact on treatment response remains uncertain. This study emulated target trials to examine the association between psychotropic co-medication at treatment onset and psychotherapy outcomes in a real-world PTSD cohort.

Methods

A prospective cohort of 6,125 adults with chronic or delayed-onset PTSD received a standardized 2–8 day trauma-focused psychotherapy program, including daily prolonged exposure and eye movement desensitization and reprocessing (EMDR) therapy, at a Dutch psychotrauma center (2021–2024). Target trial emulation with double machine learning with inverse probability of treatment weighting estimated the effects of specific psychotropic co-medications versus non-use on changes in Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) scores (range, 0–80) from pre-to post-treatment.

Results

Mean CAPS-5 scores improved by 25.7 points (Cohen’s d = −2.30). Psychotropic co-medication (n = 1,382) was associated with reduced symptom improvement compared with non-use (model-estimated difference = −2.52 points; relative reduction = −9.4%, 95% CI = −10.0 to −8.9; d = −1.11, E = 10.0). This effect persisted at 6-month follow-up (d = −0.42). Antidepressants overall (d = −0.28; follow-up d = −0.56), amitriptyline (d = −0.51), and mirtazapine (d = −0.29) were consistently associated with poorer outcomes across sensitivity analyses. Similar patterns were observed for anticonvulsants, mood-stabilizing anticonvulsants, antipsychotics, fluoxetine, zolpidem, and zopiclone. Sensitivity analyses and E-values indicated robustness to unmeasured confounding.

Conclusion

Several psychotropic co-medications were associated with reduced outcomes of evidence-based trauma-focused psychotherapy for PTSD. By identifying this as a potentially modifiable factor, psychotherapy outcomes may be optimized. Trials are warranted to evaluate whether tapering or substituting these agents improves outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stress Disorders, Post-TraumaticPsychotropic DrugsPsychotherapyOutcome Assessment, Health CareHumansAdultFemaleMaleCombined Modality TherapyProspective StudiesTreatment OutcomeMiddle AgedEye Movement Desensitization ReprocessingNetherlands

Stichwörter der Autor:innen

AnticonvulsantsAntidepressive agentsAntipsychotic AgentsDouble machine learningHypnotics and sedativesPsychotherapyStress disorders Post-traumaticTarget trial emulation

Substanzen

Psychotropic Drugs

Autor:innen und Institutionen

  • Department of Oral Public Health, University of Amsterdam and VU University Amsterdam, Amsterdam, The Netherlands.
  • Department of Oral and Maxillofacial Surgery, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
  • Department of Psychiatry, Parnassia Psychiatric Institute, Amsterdam, The Netherlands.
  • Department of Psychology and Neuroscience (IoPPN), Institute of Psychiatry, King's College London, London, UK.
  • St. John's National Academy of Health Sciences, Bangalore, India.
  • Department of Data and Analytics, Amsterdam University Medical Centers, Amsterdam, The Netherlands.

Zitieren

APA

Steenen, S. A., van Westrhenen, R., Steenen, C. C., Klausch, L. T., & de Jongh, A. (2025). Concomitant Psychotropic Medication Is Associated with Reduced Outcomes of Trauma-Focused Psychotherapy for Post-Traumatic Stress Disorder. Psychotherapy and Psychosomatics. https://doi.org/10.1159/000549259

Vancouver

Steenen SA, van Westrhenen R, Steenen CC, Klausch LT, de Jongh A. Concomitant Psychotropic Medication Is Associated with Reduced Outcomes of Trauma-Focused Psychotherapy for Post-Traumatic Stress Disorder. Psychotherapy and Psychosomatics. 2025. doi:10.1159/000549259

BibTeX
@article{Steenen2025,
  author = {Steenen, Serge A and van Westrhenen, Roos and Steenen, Camilo C and Klausch, L Thomas and de Jongh, Ad},
  title = {Concomitant Psychotropic Medication Is Associated with Reduced Outcomes of Trauma-Focused Psychotherapy for Post-Traumatic Stress Disorder},
  journal = {Psychotherapy and Psychosomatics},
  year = {2025},
  doi = {10.1159/000549259}
}
Kostenlos starten →